{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:30:47Z","timestamp":1749565847393,"version":"3.33.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004441","name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03555-z","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:53:19Z","timestamp":1736923999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Endocervical adenocarcinomas and HPV genotyping in an HIV endemic milieu \u2013 a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Luc\u00edlia","family":"Lovane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella Lillsunde","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Tulsid\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f6ren","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"3555_CR1","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1158\/1055-9965.EPI-05-0231","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005;14:2191\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3555_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bjc.6690666","volume":"81","author":"R Bergstr\u00f6m","year":"1999","unstructured":"Bergstr\u00f6m R, Spar\u00e9n P, Adami H-O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81:159\u201366.","journal-title":"Br J Cancer"},{"key":"3555_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5858\/arpa.2018-0259-RA","volume":"143","author":"A Hodgson","year":"2019","unstructured":"Hodgson A, Park KJ. Cervical Adenocarcinomas: A Heterogeneous Group of Tumors With Variable Etiologies and Clinical Outcomes. Arch Pathol Lab Med. 2019;143:34\u201346.","journal-title":"Arch Pathol Lab Med"},{"key":"3555_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890\u2013907.","journal-title":"Lancet"},{"key":"3555_CR5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1158\/1055-9965.EPI-12-0334","volume":"21","author":"L Denny","year":"2012","unstructured":"Denny L, Anorlu R. Cervical cancer in Africa. Cancer Epidemiol Biomarkers Prev. 2012;21:1434\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3555_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3555_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3555_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","volume":"42","author":"S Stolnicu","year":"2018","unstructured":"Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, et al. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix. Am J Surg Pathol. 2018;42:214\u201326.","journal-title":"Am J Surg Pathol"},{"key":"3555_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/his.13995","volume":"76","author":"KJ Park","year":"2020","unstructured":"Park KJ. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification. Histopathology. 2020;76:112\u201327.","journal-title":"Histopathology"},{"key":"3555_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048\u201356.","journal-title":"Lancet Oncol"},{"key":"3555_CR11","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/PGP.0000000000000751","volume":"40","author":"S Stolnicu","year":"2021","unstructured":"Stolnicu S, Park KJ, Kiyokawa T, Oliva E, McCluggage WG, Soslow RA. Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2021;40:S75\u201391.","journal-title":"Int J Gynecol Pathol"},{"key":"3555_CR12","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/ijc.33124","volume":"147","author":"D Jenkins","year":"2020","unstructured":"Jenkins D, Molijn A, Kazem S, Pirog EC, Alemany L, de Sanjose S, et al. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study. Int J Cancer. 2020;147:2526\u201336.","journal-title":"Int J Cancer"},{"key":"3555_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/1471-2407-13-553","volume":"13","author":"JM Pimenta","year":"2013","unstructured":"Pimenta JM, Galindo C, Jenkins D, Taylor SM. Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination. BMC Cancer. 2013;13:553.","journal-title":"BMC Cancer"},{"key":"3555_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/modpathol.3800316","volume":"18","author":"HJ An","year":"2005","unstructured":"An HJ, Kim KR, Kim IS, Kim DW, Park MH, Park IA, et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Mod Pathol. 2005;18:528\u201334.","journal-title":"Mod Pathol"},{"key":"3555_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.mpdhp.2021.09.002","volume":"27","author":"S Stolnicu","year":"2021","unstructured":"Stolnicu S. Cervical cancer: what\u2019s new in classification, morphology, molecular findings and prognosis of glandular precursor and invasive lesions. Diagn Histopathol. 2021;27:483\u201392.","journal-title":"Diagn Histopathol"},{"key":"3555_CR16","unstructured":"WHO, editor. Female Genital Tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2020."},{"key":"3555_CR17","unstructured":"IARC. 508-mozambique-fact-sheet.In: Global Cancer Observatory. 2021. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/508-mozambique-fact-sheet.pdf. Accessed 24 Jan 2023."},{"key":"3555_CR18","doi-asserted-by":"publisher","first-page":"e015653","DOI":"10.1136\/bmjopen-2016-015653","volume":"7","author":"V Edna Omar","year":"2017","unstructured":"Edna Omar V, Orvalho A, N\u00e1lia I, Malin K, Gabriella L-L, Torbj\u00f6rn R, et al. Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city,\u00a0Mozambique. BMJ Open. 2017;7:e015653.","journal-title":"BMJ Open."},{"key":"3555_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/v14010024","volume":"14","author":"C Maueia","year":"2021","unstructured":"Maueia C, Murahwa A, Manjate A, Andersson S, Sacarlal J, Kenga D, et al. Identification of the Human Papillomavirus Genotypes, According to the Human Immunodeficiency Virus Status in a Cohort of Women from Maputo, Mozambique. Viruses. 2021;14:12.","journal-title":"Viruses"},{"key":"3555_CR20","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/ijgc-2020-001643","volume":"30","author":"MP Salcedo","year":"2020","unstructured":"Salcedo MP, Oliveira C, Andrade V, Mariano AAN, Changule D, Rangeiro R, et al. The Capulana study: a prospective evaluation of cervical cancer screening using human papillomavirus testing in Mozambique. Int J Gynecol Cancer. 2020;30:1292\u20137.","journal-title":"Int J Gynecol Cancer"},{"key":"3555_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12889-020-10039-2","volume":"21","author":"MAS Boothe","year":"2021","unstructured":"Boothe MAS, Sathane I, Baltazar CS, Chicuecue N, Horth R, Fazito E, et al. Low engagement in HIV services and progress through the treatment cascade among key populations living with HIV in Mozambique: alarming gaps in knowledge of status. BMC Public Health. 2021;21:146.","journal-title":"BMC Public Health"},{"key":"3555_CR22","unstructured":"Minist\u00e9rio da Sa\u00fade M, Instituto Nacional de Estat\u00edstica I, ICF. Survey of Indicators on Immunization, Malaria and HIV\/AIDS in Mozambique 2015: Supplemental Report Incorporating Antiretroviral Biomarker Results.2019. https:\/\/dhsprogram.com\/publications\/publication-ais12-ais-final-reports.cfm. Accessed 24 Jan 2023."},{"key":"3555_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000526270","volume":"87","author":"R Wang","year":"2022","unstructured":"Wang R, Zhang Y, Zhu Y, Li Q. Clinical Characteristics and Prognosis of Cervical Cancer Patients with Human Immunodeficiency Virus Infection: A Retrospective Study. Gynecol Obstet Invest. 2022;87:324\u201332.","journal-title":"Gynecol Obstet Invest"},{"key":"3555_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/cid\/ciab561","volume":"74","author":"AF Rositch","year":"2022","unstructured":"Rositch AF, Levinson K, Suneja G, Monterosso A, Schymura MJ, McNeel TS, et al. Epidemiology of Cervical Adenocarcinoma and Squamous Cell Carcinoma Among Women Living With Human Immunodeficiency Virus Compared With the General Population in the United States. Clin Infect Dis. 2022;74:814\u201320.","journal-title":"Clin Infect Dis"},{"key":"3555_CR25","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization; 2021."},{"key":"3555_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1186\/s12889-016-3530-y","volume":"16","author":"KP Msyamboza","year":"2016","unstructured":"Msyamboza KP, Phiri T, Sichali W, Kwenda W, Kachale F. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study. BMC Public Health. 2016;16:806.","journal-title":"BMC Public Health"},{"key":"3555_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/CEJ.0000000000000459","volume":"28","author":"M Brandao","year":"2019","unstructured":"Brandao M, Tulsidas S, Damasceno A, Silva-Matos C, Carrilho C, Lunet N. Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique. Eur J Cancer Prev. 2019;28:338\u201343.","journal-title":"Eur J Cancer Prev"},{"key":"3555_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3390\/cancers15041163","volume":"15","author":"S Tulsidas","year":"2023","unstructured":"Tulsidas S, Fontes F, Brandao M, Lunet N, Carrilho C. Oncology in Mozambique: Overview of the Diagnostic, Treatment, and Research Capacity. Cancers (Basel). 2023;15:1163.","journal-title":"Cancers (Basel)"},{"key":"3555_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/ijc.34779","volume":"154","author":"S Tulsidas","year":"2024","unstructured":"Tulsidas S, Fontes F, Monteiro K, Mussa M, Lovane L, Morais AG, et al. Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016\u20132018. Int J Cancer. 2024;154:1019\u201328.","journal-title":"Int J Cancer"},{"key":"3555_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jmoldx.2014.12.004","volume":"17","author":"G Lillsunde Larsson","year":"2015","unstructured":"Lillsunde Larsson G, Carlsson J, Karlsson MG, Helenius G. Evaluation of HPV Genotyping Assays for Archival Clinical Samples. J Mol Diagn. 2015;17:293\u2013301.","journal-title":"J Mol Diagn"},{"key":"3555_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/PGP.0000000000000612","volume":"39","author":"M Kaliff","year":"2020","unstructured":"Kaliff M, Karlsson MG, Sorbe B, Bohr Mordhorst L, Helenius G, Lillsunde-Larsson G. HPV-negative Tumors in a Swedish Cohort of Cervical Cancer. Int J Gynecol Pathol. 2020;39:279\u201388.","journal-title":"Int J Gynecol Pathol"},{"key":"3555_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang F, Flanagan J, Su N, Wang L-C, Bui S, Nielson A, et al. RNAscope: A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagn. 2012;14:22\u20139.","journal-title":"J Mol Diagn"},{"key":"3555_CR33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s12105-022-01463-4","volume":"16","author":"SA Rasmussen","year":"2022","unstructured":"Rasmussen SA, Lewis JS Jr, Mirabello L, Bass S, Yeager M, Corsten MJ, et al. A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression. Head Neck Pathol. 2022;16:1251\u20136.","journal-title":"Head Neck Pathol"},{"key":"3555_CR34","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/PAS.0b013e318265fb2b","volume":"36","author":"JA Bishop","year":"2012","unstructured":"Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6\/E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874\u201382.","journal-title":"Am J Surg Pathol"},{"key":"3555_CR35","doi-asserted-by":"publisher","first-page":"e31310","DOI":"10.1097\/MD.0000000000031310","volume":"101","author":"TY Chen","year":"2022","unstructured":"Chen TY, Yang HW, Lin DS, Huang ZD, Chang L. HIV fragments detected in Kaposi sarcoma tumor cells in HIV-infected patients. Medicine (Baltimore). 2022;101: e31310.","journal-title":"Medicine (Baltimore)"},{"key":"3555_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12977-017-0387-9","volume":"15","author":"C Deleage","year":"2018","unstructured":"Deleage C, Chan CN, Busman-Sahay K, Estes JD. Next-generation in situ hybridization approaches to define and quantify HIV and SIV reservoirs in tissue microenvironments. Retrovirology. 2018;15:4.","journal-title":"Retrovirology"},{"key":"3555_CR37","unstructured":"Instituto Nacional de Sa\u00fade I. Mozambique Population-based HIV Impact Assessment 2021 (INSIDA 2021): Final Report2022. https:\/\/phia.icap.columbia.edu\/mozambique-summary-sheet-en-pt-2021\/. Accessed 20 Nov 2023."},{"key":"3555_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.20411\/pai.v1i1.100","volume":"1","author":"C Deleage","year":"2016","unstructured":"Deleage C, Wietgrefe SW, Del Prete G, Morcock DR, Hao XP, Piatak M Jr, et al. Defining HIV and SIV Reservoirs in Lymphoid Tissues. Pathog Immun. 2016;1:68\u2013106.","journal-title":"Pathog Immun"},{"key":"3555_CR39","doi-asserted-by":"publisher","first-page":"113198","DOI":"10.1016\/j.jim.2021.113198","volume":"501","author":"ZA Richardson","year":"2022","unstructured":"Richardson ZA, Deleage C, Tutuka CSA, Walkiewicz M, Del Rio-Estrada PM, Pascoe RD, et al. Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue. J Immunol Methods. 2022;501: 113198.","journal-title":"J Immunol Methods"},{"key":"3555_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00428-019-02601-0","volume":"475","author":"S Stolnicu","year":"2019","unstructured":"Stolnicu S, Hoang L, Soslow RA. Recent advances in invasive adenocarcinoma of the cervix. Virchows Arch. 2019;475:537\u201349.","journal-title":"Virchows Arch"},{"key":"3555_CR41","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1097\/QAD.0000000000002962","volume":"35","author":"EA Stier","year":"2021","unstructured":"Stier EA, Engels E, Horner MJ, Robinson WT, Qiao B, Hayes J, et al. Cervical cancer incidence stratified by age in women with HIV compared with the general population in the United States, 2002\u20132016. AIDS. 2021;35:1851\u20136.","journal-title":"AIDS"},{"key":"3555_CR42","doi-asserted-by":"publisher","first-page":"e27030","DOI":"10.1097\/MD.0000000000027030","volume":"100","author":"MM Mohosho","year":"2021","unstructured":"Mohosho MM. HIV prevalence in patients with cervical carcinoma: A cohort study at a secondary hospital in South Africa. Medicine (Baltimore). 2021;100: e27030.","journal-title":"Medicine (Baltimore)"},{"key":"3555_CR43","doi-asserted-by":"publisher","first-page":"100516","DOI":"10.1016\/j.gore.2019.100516","volume":"31","author":"ES Wu","year":"2020","unstructured":"Wu ES, Urban RR, Krantz EM, Mugisha NM, Nakisige C, Schwartz SM, et al. The association between HIV infection and cervical cancer presentation and survival in Uganda. Gynecol Oncol Rep. 2020;31: 100516.","journal-title":"Gynecol Oncol Rep"},{"key":"3555_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/1055-9965.EPI-19-0538","volume":"29","author":"SG Craig","year":"2020","unstructured":"Craig SG, Anderson LA, Moran M, Graham L, Currie K, Rooney K, et al. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland. Cancer Epidemiol Biomarkers Prev. 2020;29:31\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3555_CR45","doi-asserted-by":"publisher","first-page":"102782","DOI":"10.1016\/j.amjoto.2020.102782","volume":"42","author":"K Suresh","year":"2021","unstructured":"Suresh K, Shah PV, Coates S, Alexiev BA, Samant S. In situ hybridization for high risk HPV E6\/E7 mRNA in oropharyngeal squamous cell carcinoma. Am J Otolaryngol. 2021;42: 102782.","journal-title":"Am J Otolaryngol"},{"key":"3555_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5858\/arpa.2022-0317-OA","volume":"148","author":"G Haqshenas","year":"2023","unstructured":"Haqshenas G, Molano M, Phillips S, Balgovind P, Garland SM, Hawkes D, et al. Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens. Arch Pathol Lab Med. 2023;148:353\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"3555_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40291-021-00570-2","volume":"26","author":"S Atout","year":"2022","unstructured":"Atout S, Shurrab S, Loveridge C. Evaluation of the Suitability of RNAscope as a Technique to Measure Gene Expression in Clinical Diagnostics: A Systematic Review. Mol Diagn Ther. 2022;26:19\u201337.","journal-title":"Mol Diagn Ther"},{"key":"3555_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1186\/s12935-021-02349-1","volume":"21","author":"RZ Luo","year":"2021","unstructured":"Luo RZ, Chen SL, Li M, Li Y, Yang X, Liu LL. HPV E6\/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis. Cancer Cell Int. 2021;21:643.","journal-title":"Cancer Cell Int"},{"key":"3555_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41379-019-0360-3","volume":"33","author":"I Nicolas","year":"2020","unstructured":"Nicolas I, Saco A, Barnadas E, Marimon L, Rakislova N, Fuste P, et al. Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix. Mod Pathol. 2020;33:128\u201337.","journal-title":"Mod Pathol"},{"key":"3555_CR50","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/ijms22052294","volume":"22","author":"S da Mata","year":"2021","unstructured":"da Mata S, Ferreira J, Nicolas I, Esteves S, Esteves G, Lerias S, et al. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers. Int J Mol Sci. 2021;22:2294.","journal-title":"Int J Mol Sci"},{"key":"3555_CR51","doi-asserted-by":"publisher","first-page":"864820","DOI":"10.3389\/fonc.2022.864820","volume":"12","author":"J Williams","year":"2022","unstructured":"Williams J, Kostiuk M, Biron VL. Molecular Detection Methods in HPV-Related Cancers. Front Oncol. 2022;12: 864820.","journal-title":"Front Oncol"},{"key":"3555_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jmv.24645","volume":"89","author":"Z Wu","year":"2017","unstructured":"Wu Z, Qin Y, Yu L, Lin C, Wang H, Cui J, et al. Association between human papillomavirus (HPV) 16, HPV18, and other HR-HPV viral load and the histological classification of cervical lesions: Results from a large-scale cross-sectional study. J Med Virol. 2017;89:535\u201341.","journal-title":"J Med Virol"},{"key":"3555_CR53","first-page":"666","volume":"21","author":"A Chrysagi","year":"2016","unstructured":"Chrysagi A, Kaparos G, Vrekoussis T, Yiannou P, Messini I, Patsouris E, et al. Prevalence of HPV genotypes in cervical adenocarcinoma a study in Greek women. JBUON. 2016;21:666\u201372.","journal-title":"JBUON"},{"key":"3555_CR54","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1038\/s41467-024-47909-x","volume":"15","author":"LS Arroyo Muhr","year":"2024","unstructured":"Arroyo Muhr LS, Gini A, Yilmaz E, Hassan SS, Lagheden C, Hultin E, et al. Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer. Nat Commun. 2024;15:3679.","journal-title":"Nat Commun"},{"key":"3555_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2012","unstructured":"Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:100\u201310.","journal-title":"Lancet Oncol"},{"key":"3555_CR56","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12879-024-09166-7","volume":"24","author":"PK Akakpo","year":"2024","unstructured":"Akakpo PK, Imbeah EG, Ulzen-Appiah K, Darkwa-Abrahams A, Adjei E, Amo-Antwi K, et al. The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study. BMC Infect Dis. 2024;24:356.","journal-title":"BMC Infect Dis."},{"key":"3555_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13027-024-00596-1","volume":"19","author":"G Murenzi","year":"2024","unstructured":"Murenzi G, Vuhahula E, Kimambo A, Matiku S, Tuyishime O, Liwa E, et al. High-risk human papillomavirus genotyping in cervical cancers in Tanzania. Infect Agent Cancer. 2024;19:35.","journal-title":"Infect Agent Cancer"},{"key":"3555_CR58","unstructured":"MISAU. Programa Nacional de Controlo do Cancro 2019\u201320292019. https:\/\/www.iccp-portal.org\/system\/files\/plans\/PLANO%20NACIONAL%20DE%20CONTROLO%20DO%20CANCRO_miolo-3.pdf. Accessed 29 Sept 2023."},{"key":"3555_CR59","unstructured":"Dillner J. [Human papillomavirus type 18 - In memoriam]. 2024."},{"key":"3555_CR60","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1470-2045(22)00291-1","volume":"23","author":"JZ Shing","year":"2022","unstructured":"Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN, et al. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial. Lancet Oncol. 2022;23:940\u20139.","journal-title":"Lancet Oncol"},{"key":"3555_CR61","doi-asserted-by":"publisher","first-page":"200263","DOI":"10.1016\/j.tvr.2023.200263","volume":"16","author":"PL Stern","year":"2023","unstructured":"Stern PL. Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia? Tumour Virus Res. 2023;16: 200263.","journal-title":"Tumour Virus Res"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03555-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03555-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03555-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T07:49:00Z","timestamp":1736927340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03555-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3555"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03555-z","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the National Bioethics Committee for Health (CNBS) board of Mozambique under registration number 114\/CNBS\/2019 and Swedish Ethical Review Authority under registration number 2023\u201301674-01\u2013423571, according to the Helsinki Declaration in human subject research. The tissue material consists of formalin fixed paraffin embedded (FFPE) blocks of invasive cervical cancer samples from biopsy or surgery obtained and sent to the Pathology Department of Maputo Central Hospital for diagnostic purposes on 2017\u20142018. The tissue samples were strictly anonymized before inclusion in the present study. The informed written consent was waived from the study protocol by the CNBS. No further sampling, treatment or contact with the patients was needed. The new information received would not change any potential forthcoming treatment or outcome for the individual patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}